Date: 2015-11-02
Type of information: Company acquisition
Acquired company: Seahorse Bioscience (USA - MA)
Acquiring company: Agilent Technologies (USA - CA)
Amount: $235 million
Terms: * On November 2, 2015, Agilent Technologies announced it has completed the acquisition of Seahorse Bioscience, a leader in providing instruments and assay kits for measuring cell metabolism and bioenergetics. Agilent announced its intent to acquire Seahorse on Sept. 9 (See below). With the completion of the acquisition, most of the 200 employees who were with Seahorse are now part of the Mass Spectrometry Division of Agilent\'s Life Sciences and Applied Markets Group. * On September 9, 2015, Agilent Technologies and Seahorse Bioscience announced they have signed a definitive agreement under which Agilent will acquire Seahorse Bioscience, a leader in providing instruments and assay kits for measuring cell metabolism and bioenergetics. Agilent is acquiring Seahorse Bioscience for $235 million in cash. Seahorse\'s FY15 revenue is estimated to be $49 million. The transaction is expected to be accretive in FY16 to Agilent and will be debt financed. The acquisition is expected to be completed by Nov. 1, subject to local laws and regulations and customary closing conditions.
Details: Privately held Seahorse Bioscience, founded in 2001, is headquartered in Billerica, Massachusetts, with manufacturing operations in Chicopee, Massachusetts. Regional offices are in Copenhagen, Denmark, and Shanghai, China. Seahorse Bioscience\'s leading technology enables researchers to better understand cell health, function and signaling, and how the cell may be impacted by the introduction of a specific drug, by providing real-time kinetics to unlock essential cellular bioenergetics data. Agilent acquired Seahorse Bioscience because its unique technology complements Agilent\'s leading separations and mass spectrometry solutions, in particular for metabolomics and disease research in pharma. Scientists use Seahorse Bioscience\'s proprietary XF Technology to research the role of cell metabolism in neurodegeneration, aging, cancer, cardiovascular disease, cell physiology, toxicology and hepatobiology, immunology, infectious diseases, mitochondrial diseases, model organisms, obesity, diabetes, metabolic disorders, screening and translational medicine.
Related: Technology - Services
